[How will drugs be prescribed in the future for patients with cardiac insufficiency?].
Komajda
M
M
Hôpital La Pitié-La Salpêtrière, Paris.
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage; D002303:Cardiac Output, Low / Q000150:complications / Q000188:drug therapy*; D002317:Cardiovascular Agents / Q000008:administration & dosage*; D048909:Diabetes Complications; D004232:Diuretics / Q000008:administration & dosage; D011307:Drug Prescriptions; D005544:Forecasting; D006801:Humans; D010597:Pharmacogenetics; D012307:Risk Factors; D015996:Survival Rate
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D002317:Cardiovascular Agents; D004232:Diuretics